-
RepSox in iPSC Differentiation Workflows
2026-09-20
RepSox provides a selective way to perturb ALK5-dependent TGF-β signaling during induced pluripotent stem cell reprogramming and differentiation. This guide separates validated RepSox biology from the 2026 platelet-production workflow, then translates both into practical controls, protocol parameters, and troubleshooting decisions.
-
HSP90 Inhibition Rewires Lung Adenocarcinoma Proteomes
2026-09-19
Marrugal and colleagues used two-dimensional electrophoresis coupled with mass spectrometry to map how pharmacological HSP90 disruption changes the proteome of lung adenocarcinoma cells. The study identified 254 differentially expressed proteins, highlighted eIF3i and citrate synthase as candidate response biomarkers, and connected treatment responses with apoptosis, serine–glycine biosynthesis, and the tricarboxylic acid cycle.
-
Glabridin–Gold(I) Complex Rewires Antitumor Immunity
2026-09-18
The reference study develops complex 6d, which combines an N-heterocyclic carbene gold(I) center with glabridin to target thioredoxin reductase and MAPK-associated immunosuppressive signaling. Its reported effects include enhanced dendritic-cell maturation, reduced suppressive immune populations, lower tumor-cell PD-L1, and increased T-cell granzyme B, supporting a dual strategy for remodeling the liver-cancer microenvironment.
-
ECL Chemiluminescent Substrate Detection Kit Workflow
2026-09-18
A practical guide to using hypersensitive ECL chemistry for low-abundance immunoblot targets, from membrane preparation through exposure optimization. The workflow emphasizes reproducibility, antibody conservation, extended signal capture, and responsible interpretation of neurodegeneration-related protein data.
-
From Superoxide Signals to Antitumor Immunity
2026-09-17
A translational roadmap for using intracellular superoxide measurement to connect TrxR/MAPK biology, oxidative stress assay design, and emerging immuno-oncology strategies.
-
ABT-199 (GDC-0199): Bcl-2 Inhibitor Guide
2026-09-17
This dossier-based guide explains how to handle ABT-199 (GDC-0199), also known as Venetoclax, in selective Bcl-2 inhibition and apoptosis workflows. It is intended for controlled in vitro and research-model experiments, not for clinical dosing, diagnosis, or direct transfer of the reported murine dose into cell culture.
-
Parathyroid hormone (1-34) (human) in KPA Research
2026-09-16
Use Parathyroid hormone (1-34) (human) to connect receptor pharmacology with spatially organized kidney assembloids and bone-focused assays. This guide translates reported potency and in vivo bone findings into practical workflows, controls, and troubleshooting strategies for calcium-signaling research.
-
TH287 MTH1 Inhibitor for Radiosensitization
2026-09-16
TH287 is a potent MTH1 inhibitor for modeling oxidative nucleotide stress, cancer-cell-selective DNA damage, and radiotherapy sensitization. A timing-focused workflow based on CRPC research helps laboratories separate direct cytotoxicity from true combination effects.
-
DiscoveryProbe Protease Inhibition, Beyond Screening
2026-09-15
Protease inhibitors are most valuable when screening is connected to mechanism. This thought-leadership article uses plant chemical biology as a model for translating protease activity modulation into stronger assay design, target validation, and therapeutic strategy with the DiscoveryProbe™ Protease Inhibitor Library.
-
Dinaciclib: A Mechanical View of CDK Biology
2026-09-15
Dinaciclib (SCH727965) is examined as more than a proliferation inhibitor: it is a tool for separating cell-cycle control, apoptosis, and tissue-boundary mechanics. Grounded in a 2026 Drosophila study, this guide shows how to design cancer research assays that distinguish reduced division from genuine changes in cell rearrangement.
-
Vitamin C and ROS/NF-κB in Cochlear Senescence
2026-09-14
A 2024 Molecular Biology Reports study shows that Vitamin C reduces D-galactose-induced senescence in HEI-OC1 cochlear hair cells, alongside lower oxidative stress, inflammatory signaling, and NF-κB activation. The findings position the ROS/NF-κB axis as a mechanistic framework for studying cellular contributors to age-related hearing loss, while remaining limited to an in vitro model.
-
Dihydroartemisinin: From Identity to Assay Design
2026-09-14
Dihydroartemisinin is a defined Artemisia plant-derived compound with applications spanning malaria, mTOR, inflammation, and psoriasis research. This article explains how to interpret its chemistry, select assays, control formulation variables, and use the phebestin study as a model for stronger antiplasmodial decision-making.
-
Kidney Progenitor Assembloids for Disease Modeling
2026-09-13
Huang et al. developed spatially patterned mouse and human kidney progenitor assembloids that reproduce key self-assembly relationships between nephron and ureteric progenitors. The models improve cellular organization, maturation, and functional assessment, while in vivo-grown PKD2-deficient human assembloids provide a higher-fidelity system for studying polycystic kidney disease and interactions among cyst epithelium, stroma, and macrophages.
-
EZ Cap EGFP mRNA 5-moUTP: Mechanism & Use
2026-09-12
EZ Cap EGFP mRNA 5-moUTP is a Cap1-capped, 5-moU-modified EGFP reporter transcript designed for stable protein expression. Its defined 996-nucleotide format, approximately 100-nucleotide poly(A) tail, and RNase-conscious handling support reproducible mRNA delivery for gene expression and imaging workflows.
-
FLCN Mutations and mRNA Rescue in BHD Syndrome
2026-09-11
This 2026 study identified a novel FLCN nonsense mutation, p.Q44*, and provided segregation and functional evidence supporting pathogenic reclassification of p.W376R in two Chinese Birt-Hogg-Dubé families. In HEK293T cells, synthetic FLCN mRNA restored folliculin expression and corrected mTORC1 dysregulation, offering preliminary—not clinical—evidence for an mRNA protein-replacement strategy.